US Markets
Home›US Markets›Sectors›Startup uses AI to guide rare disease families from ge…
Startup uses AI to guide rare disease families from genetic diagnosis to treatments
CNBC Markets highlights Nome, a startup that applies artificial intelligence alongside drug-development expertise to help rare disease families translate genetic diagnoses into potential paths toward treatment.
The company’s approach is aimed at reducing the gap between identifying a condition and understanding what treatment development could look like for patients with specific genetic findings, according to CNBC Markets.
← Newer storyNvidia leans on capital edge as AI chip competition intensifiesOlder story →Bitcoin faces long-duration Treasury competition as yields near 5.3%